Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture

Pharmazie

Volumn 62, Issue 5, 2007, Pages 388-391

  Chen, Ke Ming ^a   Ge, B F ^a   Liu, X Y ^a   Ma, H P ^a   Lu, M B ^a   Bai, M H ^a   Wang, Y ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; COLONY STIMULATING FACTOR 1; ICARIIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; HEMATOPOIETIC CELL; IN VITRO STUDY; MARKER GENE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; PHASE CONTRAST MICROSCOPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACID PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE RESORPTION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIMEDIUM; FLAVONOIDS; ISOENZYMES; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED BALB C; MICROSCOPY, PHASE-CONTRAST; OSTEOCLASTS; RABBITS; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34249810332     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.5.6682     Document Type: Article

References (9)

1. Blair HC, Athanasou NA (2004) Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 19:189-199.
2. Chen KM, Ge BF, Ma HP et al. (2004) The serum of rats administered flavonoid extract from Epimedium sagittatum but not the extract itself enhances the development of rat calvarial osteoblast-like cells in vitro. Pharmazie 59: 61-64.
3. Chen KM, Ge BF, Ma HP et al. (2005) Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Pharmazie 60: 939-942.
4. Dang ZC, Lowik C (2005) Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol Metab 16: 207-213.
5. Duong LT, Rodan GA (2001) Regulation of osteoclast formation and function. Rev Endocrin Metabol Dis 2: 95-104.
6. Kudo O, Sabokbar A, Pocock A et al. (2002) Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts. Calcif Tissue Int 71: 539-546.
7. Michael H, Harkonen PL, Vaananen HK et al. (2005) Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 20: 2224-2232.
8. Sakiyama H, Masuda R, Inoue N et al. (2001) Establishment and characterization of macrophage-like cell lines expressing osteoclast-specific markers. J Bone Miner Metab 19: 220-227.
9. Zhang YW, Morita I, Shao G et al. (2000) Screening of anti-hypoxia/reoxygenation agents by an in vitro method. Part 2: Inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication. Planta Med 66: 119-123.